Efpeglenatide and clinical outcomes with and without concomitant sodium-glucose cotransporter-2 inhibition use in type 2 diabetes: Exploratory analysis of the AMPLITUDE-O Trial - Lam, CS P; Ramasundarahettige, C; Branch, KR H (Circulation, 2022)